GroPep Bioreagents has updated the 2019 price list to reflect the changes to the IGFBP polyclonal antibody portfolio. There are no price increases and some product sizes have increased substantially.
GroPep Bioreagents manufactures IGF-II analogues with different biological properties compared to native IGF-II. Click here for a link to a guidline to help you pick the right analogue for your Research and Development.
